Bicycle Therapeutics plc

Pharmaceutical company · Cambridge, England, United Kingdom · Nasdaq: BCYC

Bicycle Therapeutics plc is a pharmaceutical company headquartered in Cambridge, England, United Kingdom. Its shares trade on Nasdaq under the ticker BCYC. It has reported private securities offerings to the US SEC, most recently $555 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Bicycle Therapeutics at a glance

Typepharmaceutical company

HeadquartersCambridge, England, United Kingdom

Stock listingNasdaq: BCYC

SEC industryPharmaceutical Preparations

SEC CIK1761612

What does Bicycle Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $555.5 million sold (2024).

Frequently asked questions about Bicycle Therapeutics

Where is Bicycle Therapeutics headquartered?

Bicycle Therapeutics plc is headquartered in Cambridge, England, United Kingdom.

What does Bicycle Therapeutics do?

Bicycle Therapeutics plc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Bicycle Therapeutics a public company?

Yes. Bicycle Therapeutics plc trades on Nasdaq under the ticker BCYC.

Similar companies

F-star Therapeutics, Inc.Cambridge, England, United Kingdom
Astrazeneca plcCambridge, England, United Kingdom
Swedish Orphan Biovitrum LtdCambridge, England, United Kingdom
Cycle Pharmaceuticals LtdCambridge, England, United Kingdom
Silence Therapeutics plcLondon, England, United Kingdom
Kiniksa Pharmaceuticals International, plcLondon, England, United Kingdom
Biodexa Pharmaceuticals PlcCardiff, Wales, United Kingdom
Verona Pharma plcLondon, England, United Kingdom

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences